These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36568165)

  • 21. Case of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Presenting With Intravascular Localization of Tumor Cells in Skin Biopsies From Both Plaque and Normal-Appearing Skin: A Case Report and Literature Review.
    Obara K; Amoh Y
    Am J Dermatopathol; 2020 Mar; 42(3):196-203. PubMed ID: 31567394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant effusions from extranodal NK/T-cell lymphomas are frequently of anaplastic morphology with azurophilic granules and of T-cell lineage.
    Liu CY; Chen BJ; Chuang SS;
    Diagn Cytopathol; 2020 May; 48(5):453-463. PubMed ID: 32020785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary pulmonary extranodal NK/T-cell lymphoma: a case report and literature review.
    Wang Y; Wang Z; Wu C; Zhao X; Ji N; Huang M
    Transl Cancer Res; 2020 Nov; 9(11):7359-7365. PubMed ID: 35117335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological characteristics and treatment outcomes of cutaneous extranodal natural killer/T-cell lymphoma: a retrospective study in China.
    Chen X; Liu X; Liu W; Wang L; Zou L
    Transl Cancer Res; 2020 Oct; 9(10):6096-6106. PubMed ID: 35117221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
    Tsuyama N; Asaka R; Dobashi A; Baba S; Mishima Y; Ueda K; Oguchi M; Tsuji H; Hatake K; Takeuchi K
    Hematol Oncol; 2018 Feb; 36(1):328-335. PubMed ID: 28695659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy.
    Zhang YP; Zhang R; Zhu HY; Wang L; Wu YJ; Liang JH; Shi WY; Liu H; Xu W; Li JY
    Cancer Res Treat; 2019 Jan; 51(1):368-377. PubMed ID: 29764116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extranodal natural killer/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey.
    Rozas-Muñoz E; Gallardo F; Pujol RM; Pérez-Ferriols A; Servitje O; Estrach T; Bastida J; Román C; Palacio-Aller L; Gil I; Martí RM; Vidal-Sarró D; García-Muret MP
    Eur J Dermatol; 2018 Feb; 28(1):64-70. PubMed ID: 29400283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma: A multicenter study.
    Zhang Y; Ma S; Cai J; Yang Y; Jing H; Shuang Y; Peng Z; Li B; Liu P; Xia Z; Xia Y; Gao Y; Chen D; Lin J; Li Q; Xu S; Xu Q; Zhang H; Huang H; Cai Q
    Am J Hematol; 2021 Nov; 96(11):1481-1490. PubMed ID: 34449095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal-type extranodal natural killer/T-cell lymphoma presenting with a mass on the buttock: A case report.
    Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18260. PubMed ID: 31804361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extranodal natural killer/T-cell lymphoma presenting as hypopyon panuveitis: a case report.
    Sukon N; Tesavibul N; Choopong P; Panyayingyong N; Boonsopon S
    BMC Ophthalmol; 2022 Feb; 22(1):46. PubMed ID: 35100995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of primary extranodal natural killer/T-cell lymphoma in the orbit and intraocular tissues with cerebrospinal fluid involvement.
    Okada A; Harada Y; Inoue T; Okikawa Y; Ichinohe T; Kiuchi Y
    Am J Ophthalmol Case Rep; 2018 Sep; 11():37-40. PubMed ID: 29978138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case report: Mononeuropathy multiplex of extranodal natural killer/T-cell lymphoma misdiagnosed as systemic vasculitis.
    Shi J; Niu J; Wu D; Zhang L; Huang Y; Zhang H; Guan H; Liu M; Guan Y
    Front Neurol; 2023; 14():1283874. PubMed ID: 38073617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of patients treated with SVILE
    Wei L; Yang L; Ye J; Cong J; Li X; Yao N; Yang J; Cui X; Ding J; Wu Y; Wang J
    Cancer Biol Med; 2020 Aug; 17(3):795-804. PubMed ID: 32944407
    [No Abstract]   [Full Text] [Related]  

  • 35. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of P-Gemox chemotherapy combined with radiotherapy in newly diagnosed,stage ⅠE to ⅡE, extranodal nasal type natural killer/T-cell lymphoma].
    Ji J; Li L; She NN; Liu XH; Long Y; Zhang XB
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):132-137. PubMed ID: 30808138
    [No Abstract]   [Full Text] [Related]  

  • 37. Extranodal natural killer/T-cell lymphoma of the breast: a retrospective clinicopathological analysis of a consecutive 11-year case series.
    Liu W; Chen Z; Li F; Zhang W; Liu W; Zhao S
    Orphanet J Rare Dis; 2021 Nov; 16(1):479. PubMed ID: 34794461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glans metastatic extra-nodal natural killer/T-cell lymphoma, nasal-type with HDAC inhibitor as maintenance therapy: a rare case report with literature review.
    Fu C; Yang C; Li Q; Wang L; Zou L
    Ann Palliat Med; 2020 Sep; 9(5):3602-3608. PubMed ID: 32527129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes and central nervous system relapse in extranodal natural killer/T-cell lymphoma.
    Miyazaki K; Suzuki R; Oguchi M; Taguchi S; Amaki J; Maeda T; Kubota N; Maruyama D; Terui Y; Sekiguchi N; Takizawa J; Tsukamoto H; Murayama T; Ando T; Matsuoka H; Hasegawa M; Wada H; Sakai R; Kameoka Y; Tsukamoto N; Choi I; Masaki Y; Shimada K; Fukuhara N; Utsumi T; Uoshima N; Kagami Y; Asano N; Ejima Y; Katayama N; Yamaguchi M
    Hematol Oncol; 2022 Oct; 40(4):667-677. PubMed ID: 35142384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.